Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran

[1]  H. Goudarzi,et al.  Prevalence and Mechanisms of Carbapenem Resistance in Klebsiella pneumoniae and Escherichia coli: A Systematic Review and Meta-Analysis of Cross-Sectional Studies from Iran. , 2020, Microbial drug resistance.

[2]  Alireza Salimi Chirani,et al.  Decreased carO gene expression and OXA-type carbapenemases among extensively drug-resistant Acinetobacter baumannii strains isolated from burn patients in Tehran, Iran. , 2020, Acta microbiologica et immunologica Hungarica.

[3]  R. Ghorbani,et al.  The emergence of the hypervirulent Klebsiella pneumoniae (hvKp) strains among circulating clonal complex 147 (CC147) harbouring blaNDM/OXA-48 carbapenemases in a tertiary care center of Iran , 2020, Annals of Clinical Microbiology and Antimicrobials.

[4]  Se Yeon Kim,et al.  Characterization Of Chromosome-Mediated Colistin Resistance In Escherichia coli Isolates From Livestock In Korea , 2019, Infection and drug resistance.

[5]  N. Petrosillo,et al.  Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future , 2019, Journal of clinical medicine.

[6]  Richard J. Goater,et al.  Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread , 2019, Nature Microbiology.

[7]  M. Moosavian,et al.  The first report of emerging mobilized colistin-resistance (mcr) genes and ERIC-PCR typing in Escherichia coli and Klebsiella pneumoniae clinical isolates in southwest Iran , 2019, Infection and drug resistance.

[8]  Asad U. Khan,et al.  Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital. , 2019, International journal of antimicrobial agents.

[9]  B. Veeraraghavan,et al.  In-vitro activity of tigecycline and comparator agents against common pathogens: Indian experience. , 2019, Journal of infection in developing countries.

[10]  M. Haeili,et al.  Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran , 2019, Gut Pathogens.

[11]  A. Sahebkar,et al.  Carbapenem-Resistant Klebsiella Pneumoniae in Iran: a Systematic Review and Meta-Analysis , 2018, Journal of chemotherapy.

[12]  F. Rossi,et al.  Colistin-resistant Klebsiella pneumoniae co-harboring KPC and MCR-1 in a Hematopoietic Stem Cell Transplantation Unit , 2018, Bone Marrow Transplantation.

[13]  A. Tsakris,et al.  Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece. , 2018, International journal of antimicrobial agents.

[14]  V. Crivaro,et al.  Molecular Epidemiology and Virulence Profiles of Colistin-Resistant Klebsiella pneumoniae Blood Isolates From the Hospital Agency “Ospedale dei Colli,” Naples, Italy , 2018, Front. Microbiol..

[15]  P. Mathur,et al.  Multiple mutations in lipid-A modification pathway & novel fosA variants in colistin-resistant Klebsiella pneumoniae , 2018, Future science OA.

[16]  F. Shahcheraghi,et al.  Molecular epidemiology of NDM-1- and OXA-48-producing Klebsiella pneumoniae in an Iranian hospital: clonal dissemination of ST11 and ST893 , 2018, The Journal of antimicrobial chemotherapy.

[17]  Dokyun Kim,et al.  New Delhi Metallo-Beta-Lactamase-Producing Enterobacteriaceae in South Korea Between 2010 and 2015 , 2018, Front. Microbiol..

[18]  J. Chander,et al.  In vitro cost-effective methods to detect carbapenemases in Enterobacteriaceae , 2018, Journal of laboratory physicians.

[19]  F. Codjoe,et al.  Carbapenem Resistance: A Review , 2017, Medical sciences.

[20]  E. Babaei,et al.  MgrB Alterations Mediate Colistin Resistance in Klebsiella pneumoniae Isolates from Iran , 2017, Front. Microbiol..

[21]  Rong Zhang,et al.  Prevalence of fosfomycin resistance and plasmid-mediated fosfomycin-modifying enzymes among carbapenem-resistant Enterobacteriaceae in Zhejiang, China. , 2017, Journal of medical microbiology.

[22]  P. Nordmann,et al.  Real-time PCR for detection of plasmid-mediated polymyxin resistance (mcr-1) from cultured bacteria and stools. , 2016, The Journal of antimicrobial chemotherapy.

[23]  V. di Pilato,et al.  mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512 , 2016, Antimicrobial Agents and Chemotherapy.

[24]  Wei Jia,et al.  Detection of the mcr-1 Colistin Resistance Gene in Carbapenem-Resistant Enterobacteriaceae from Different Hospitals in China , 2016, Antimicrobial Agents and Chemotherapy.

[25]  A. Petroni,et al.  First Description of mcr-1-Mediated Colistin Resistance in Human Infections Caused by Escherichia coli in Latin America , 2016, Antimicrobial Agents and Chemotherapy.

[26]  Yi-Wei Tang,et al.  Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. , 2016, The Lancet. Infectious diseases.

[27]  D. Crook,et al.  Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae. , 2016, The Lancet. Infectious diseases.

[28]  D. Paterson,et al.  Colistin resistance: a major breach in our last line of defence. , 2016, The Lancet. Infectious diseases.

[29]  Jianzhong Shen,et al.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. , 2015, The Lancet. Infectious diseases.

[30]  Johan Bengtsson-Palme,et al.  Antibiotic resistance genes in the environment: prioritizing risks , 2015, Nature Reviews Microbiology.

[31]  Y. Ma,et al.  Characterization of fosA5, a new plasmid‐mediated fosfomycin resistance gene in Escherichia coli , 2015, Letters in applied microbiology.

[32]  Yi-Tsung Lin,et al.  Colistin Resistance Mechanisms in Klebsiella pneumoniae Strains from Taiwan , 2015, Antimicrobial Agents and Chemotherapy.

[33]  Serge Morand,et al.  Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..

[34]  M. Adams,et al.  Genomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Multiple Pathways of Resistance , 2014, Antimicrobial Agents and Chemotherapy.

[35]  K. Ko,et al.  Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates. , 2014, International journal of antimicrobial agents.

[36]  C. Gartzonika,et al.  The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece. , 2014, The Journal of antimicrobial chemotherapy.

[37]  V. di Pilato,et al.  MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin , 2014, Antimicrobial Agents and Chemotherapy.

[38]  Mohibur Rahman,et al.  Prevalence and molecular characterisation of New Delhi metallo-β-lactamases NDM-1, NDM-5, NDM-6 and NDM-7 in multidrug-resistant Enterobacteriaceae from India. , 2014, International journal of antimicrobial agents.

[39]  I. Mitov,et al.  Predominance of IncL/M and IncF plasmid types among CTX‐M‐ESBL‐producing Escherichia coli and Klebsiella pneumoniae in Bulgarian hospitals , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[40]  P. Nordmann,et al.  Resistance to Colistin Associated with a Single Amino Acid Change in Protein PmrB among Klebsiella pneumoniae Isolates of Worldwide Origin , 2014, Antimicrobial Agents and Chemotherapy.

[41]  D. Raoult,et al.  New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[42]  V. di Pilato,et al.  In Vivo Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment , 2014, Antimicrobial Agents and Chemotherapy.

[43]  P. Nordmann,et al.  Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria , 2014, BioMed research international.

[44]  V. di Pilato,et al.  In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator , 2013, Antimicrobial Agents and Chemotherapy.

[45]  F. Fallah,et al.  Carbapenem-Resistant Bacteria and Laboratory Detection Methods , 2013 .

[46]  R. Humphries,et al.  Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative Bacilli , 2013, Journal of Clinical Microbiology.

[47]  P. Nordmann,et al.  Rapid Detection of Carbapenemase-producing Enterobacteriaceae , 2012, Emerging infectious diseases.

[48]  M. Domínguez-Gil González,et al.  Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended‐spectrum beta‐lactamase (ESBL)‐producing enterobacteria , 2012, International journal of clinical practice.

[49]  D. Paterson,et al.  Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. , 2012, International journal of antimicrobial agents.

[50]  D. Livermore,et al.  The emerging NDM carbapenemases. , 2011, Trends in microbiology.

[51]  J. Winter,et al.  Genotyping of Environmental and Clinical Stenotrophomonas maltophilia Isolates and their Pathogenic Potential , 2011, PloS one.

[52]  G. Gherardi,et al.  Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: Genome diversity, biofilm formation, and virulence , 2011, BMC Microbiology.

[53]  D. Raoult,et al.  Real-time PCR assay allows detection of the New Delhi metallo-β-lactamase (NDM-1)-encoding gene in France. , 2011, International journal of antimicrobial agents.

[54]  M. Toleman,et al.  Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.

[55]  T. Wichelhaus,et al.  Global spread of New Delhi metallo-β-lactamase 1. , 2010, The Lancet. Infectious diseases.

[56]  R. Bonomo,et al.  Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan , 2010, Antimicrobial Agents and Chemotherapy.

[57]  R. Nation,et al.  Colistin in the 21st century , 2009, Current opinion in infectious diseases.

[58]  C. Pope,et al.  Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. , 2009, International journal of antimicrobial agents.

[59]  Y. Carmeli,et al.  Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258 , 2009, Antimicrobial Agents and Chemotherapy.

[60]  S. Stepanović,et al.  Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[61]  A. Carattoli,et al.  Identification of plasmids by PCR-based replicon typing. , 2005, Journal of microbiological methods.

[62]  S. Tavakolian,et al.  LPS Induces microRNAs -9, -192, and -205 Overexpression in Colorectal Cell Lines SW480, HCT116 , 2020 .

[63]  M. Goudarzi,et al.  In vitro antibacterial activity of curcumin-meropenem combination against extensively drug-resistant (XDR) bacteria isolated from burn wound infections , 2020, Avicenna journal of phytomedicine.

[64]  P. Nordmann,et al.  The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. , 2015, The Journal of antimicrobial chemotherapy.

[65]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[66]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[67]  L J Carbary,et al.  Hospital-acquired infections. , 1975, Nursing care.